🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase ll study of participants with untreated diffuse large B Cel...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-01-24
Trial ID
NCT06050694
Treatments Being Tested
In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Start Date
2023-03-20
Trial ID
NCT05798156
Treatments Being Tested
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2026-05-06
Trial ID
NCT07594899
Patients with diffuse large B-cell lymphoma (DLBCL) who are primary refract...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-01
Trial ID
NCT07702851
Treatments Being Tested
This is an open-label, single arm, multicenter, dose finding, Phase Ib stud...
Status
Active Not Recruiting
Location
UZ Gent
Start Date
2018-05-08
Trial ID
NCT03533283
Treatments Being Tested
This is an open label, multi-centre, phase Ib/II, parallel arm study evalua...
Status
Active Not Recruiting
Location
Concord Repatriation General Hospital
Start Date
2021-06-29
Trial ID
NCT04914741
Treatments Being Tested
This is a phase 1B, multi-center, dose-finding study of glofitamab administ...
Status
Completed
Location
University of Alabama Medical Center
Start Date
2018-03-13
Trial ID
NCT03467373
The purpose of this study is to compare the efficacy and safety of glofitam...
Status
Active Not Recruiting
Location
Alaska Oncology & Hematology, LLC
Start Date
2023-09-18
Trial ID
NCT06047080
Treatments Being Tested
The primary objective of this study is to characterize the safety and toler...
Status
Active Not Recruiting
Location
University of California San Francisco - Fresno Center for Medical Education and Research
Start Date
2022-06-17
Trial ID
NCT04970901
Treatments Being Tested
This phase I trial studies the side effects of polatuzumab vedotin when giv...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-10-27
Trial ID
NCT04231877